|Bid||93.20 x 0|
|Ask||93.50 x 0|
|Day's Range||88.50 - 93.90|
|52 Week Range||71.15 - 140.00|
|PE Ratio (TTM)||12.89|
|Earnings Date||Aug 17, 2018 - Aug 27, 2018|
|Forward Dividend & Yield||0.84 (0.83%)|
|1y Target Est||157.22|
Learn what reforms are benefiting frontier markets and discover three ETFs that can provide investors with exposure to these developing economies.
Pre-market today, WallStEquities.com has issued research reports on select Foreign Regional Banks equities, namely: Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG), Bancolombia S.A. (NYSE: CIB), First BanCorp.
NEW YORK, June 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Universal ...
Ahead of today's trading session, WallStEquities.com revisits the Foreign Regional Banks space, which comprises small- to mid-sized banks that are based outside of the United States. Under evaluation this morning are these four stocks: Bancolombia S.A. (NYSE: CIB), First BanCorp.
Moody's Investors Service (Moody's) has affirmed today Tarjeta Naranja S.A.'s (Naranja) B2 corporate family rating (CFR) and global foreign currency senior unsecured debt rating. The outlook on the ratings ...
Moody's Investors Service (Moody's) has affirmed today Banco de Galicia y Buenos Aires S.A.'s (Galicia) senior unsecured debt program and the foreign currency subordinated debt rating. The action followed ...
Grupo Financiero Galicia (GGAL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks.com highlights: Amtech Systems, Grupo Financiero Galicia S.A., Calithera Biosciences, RedHill Biopharma and Protagonist Therapeutics
Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences